Thomas Lawrence Holland, MD

Publications

Holland, TL, Chambers, HF, Boucher, HW, Corey, GR, Coleman, R, Castaneda-Ruiz, B, and Fowler, VG. "Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America (September 10, 2018).

PMID
30202941
Full Text

Huang, DB, Magnet, S, De Angelis, S, Holland, TL, File, TM, Dryden, M, Corey, GR, Torres, A, and Wilcox, MH. "Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe." Diagnostic Microbiology and Infectious Disease (September 10, 2018).

PMID
30266399
Full Text

Holland, TL, Raad, I, Boucher, HW, Anderson, DJ, Cosgrove, SE, Aycock, PS, Baddley, JW, Chaftari, A-M, Chow, S-C, Chu, VH, Carugati, M, Cook, P, Corey, GR, Crowley, AL, Daly, J, Gu, J, Hachem, R, Horton, J, Jenkins, TC, Levine, D, Miro, JM, Pericas, JM, Riska, P, Rubin, Z, Rupp, ME, Schrank, J, Sims, M, Wray, D, Zervos, M, Fowler, VG, and Staphylococcal Bacteremia Investigators, . "Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial." Jama 320, no. 12 (September 2018): 1249-1258.

PMID
30264119
Full Text

Huang, DB, Corey, GR, Holland, TL, Lodise, T, O'Riordan, W, Wilcox, MH, File, TM, Dryden, M, Balser, B, Desplats, E, and Torres, A. "Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections." International Journal of Antimicrobial Agents 52, no. 2 (August 2018): 233-240.

PMID
29783024
Full Text

Holland, TL, O'Riordan, W, McManus, A, Shin, E, Borghei, A, File, TM, Wilcox, MH, Torres, A, Dryden, M, Lodise, T, Oguri, T, Corey, GR, McLeroth, P, Shukla, R, and Huang, DB. "A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)." Antimicrobial Agents and Chemotherapy 62, no. 5 (May 2018).

PMID
29530858
Full Text

Huang, DB, O'Riordan, W, Overcash, JS, Heller, B, Amin, F, File, TM, Wilcox, MH, Torres, A, Dryden, M, Holland, TL, McLeroth, P, Shukla, R, and Corey, GR. "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 66, no. 8 (April 2018): 1222-1229.

PMID
29281036
Full Text

Huang, DB, Strader, CD, MacDonald, JS, VanArendonk, M, Peck, R, and Holland, T. "An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria." Open Forum Infectious Diseases 5, no. 2 (February 1, 2018).

Full Text

Holland, TL, and Fowler, VG. "Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST." Lancet (London, England) 391, no. 10121 (February 2018): 634-636.

PMID
29249277
Full Text

Stergiopoulos, S, Calvert, SB, Brown, CA, Awatin, J, Tenaerts, P, Holland, TL, DiMasi, JA, and Getz, KA. "Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 66, no. 1 (January 2018): 72-80.

PMID
29020279
Full Text

Ruopp, MD, Boggan, JC, Holland, TL, Stillwagon, MJ, Govert, JA, and Bae, JG. "Missing the Mark: Inaccuracy of administrative data in identification of hospitalized patients with pneumonia and results of a systematic clinical reclassification process on readmission rates." Journal of Hospital Administration 6, no. 6 (October 16, 2017): 35-35.

Full Text

Pages